Clinical Scorecard: Erin Gillaspie, M.D., M.P.H., Joins Baptist Health Herbert Wertheim Cancer Institute as Chief of Thoracic Surgery
At a Glance
Category
Detail
Condition
Thoracic oncology, with a particular focus on lung cancer
Key Mechanisms
Thoracic surgery and robotic surgery; research focuses on combining new treatments with surgery
Target Population
Patients receiving thoracic oncology care, particularly people with lung cancer
Care Setting
Baptist Health Herbert Wertheim Cancer Institute and Baptist Health Cancer Care
Key Highlights
Erin Gillaspie joined Baptist Health as chief of thoracic surgery.
She is board-certified in general surgery and thoracic surgery.
Her research focuses on combining new treatments with surgery and access to clinical trials for patients with lung cancer.
She previously led the thoracic surgery robotics program at Vanderbilt University Medical Center.
She has held leadership roles in clinical trials and professional thoracic surgery organizations.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients receiving thoracic oncology care, particularly patients with lung cancer.
Her research examines new treatments in combination with surgery and access to leading-edge clinical trials. The article provides no prescribing or dosing information.
Clinical Best Practices
Dr. Gillaspie stated her goal is to provide seamless, multidisciplinary and personalized care, with access to treatment options and clinical trials whenever appropriate.
Baptist Health Herbert Wertheim Cancer Institute has launched Eon, an AI-enabled software platform that analyzes radiology reports and helps identify and prioritize incidental findings for clinical review, in an effort to support timely, coordinated patient care.
